Sino-American Golden Harvest lasted for a short time, with a loss of 65.438+0.7 billion for three consecutive years and a negative gross profit margin. However, this company has not made positive adjustments and countermeasures in terms of economic profits, which has also caused a very serious impact on the company.
The US-China Golden Harvest Group has long been focusing on the research, development, transformation and application of advanced cancer diagnosis and treatment technologies, providing the leading overall cancer medical solution featuring precise radiotherapy in China.